N Puri1, A Majumdar, B Cuenoud
1NIA, National Institutes of Health, Baltimore, Maryland 21224, USA.
Modified oligonucleotides show promise for gene targeting. While extensive modifications enhance in vitro binding, moderate modifications yield superior in vivo gene knockout activity, suggesting a balance is key for therapeutic applications.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: